Oral administration of the 11β-hydroxysteroid-dehydrogenase type 1 inhibitor RO5093151 to patients with glaucoma: an adaptive, randomised, placebo-controlled clinical study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Oral administration of the 11β-hydroxysteroid-dehydrogenase type 1 inhibitor RO5093151 to patients with glaucoma: an adaptive, randomised, placebo-controlled clinical study

Published:2017-06 Issue:1 Volume:1 Page:e000063
ISSN:2397-3269
Container-title:BMJ Open Ophthalmology
language:en
Short-container-title:BMJ Open Ophth

Author:

Schwab Dietmar,Sturm Carolina,Portron Agnès,Fuerst-Recktenwald Sabine,Hainzl Dominik,Jordan Paul,Stewart William C,Tepedino Michael E,DuBiner Harvey

Funder

Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel

Publisher

BMJ

Subject

Ophthalmology

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of a human blood biomarker of pharmacological 11β‐hydroxysteroid dehydrogenase 1 inhibition;British Journal of Pharmacology;2023-10-19

2. 11β-HSD1 determines the extent of muscle atrophy in a model of acute exacerbation of COPD;American Journal of Physiology-Lung Cellular and Molecular Physiology;2023-04-01

3. Oral 11β-HSD1 inhibitor AZD4017 improves wound healing and skin integrity in adults with type 2 diabetes mellitus: a pilot randomized controlled trial;European Journal of Endocrinology;2022-04-01

4. Endogenous Glucocorticoid Metabolism in Bone: Friend or Foe;Frontiers in Endocrinology;2021-08-27

5. An Open-label Phase I/IIa Clinical Trial of 11β-HSD1 Inhibitor for Cushing’s Syndrome and Autonomous Cortisol Secretion;The Journal of Clinical Endocrinology & Metabolism;2021-06-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP